Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Erica Binetti"'
Autor:
Alessandro Russo, Elio Gentilini Cacciola, Cristian Borrazzo, Valeria Filippi, Tommaso Bucci, Francesco Vullo, Luigi Celani, Erica Binetti, Luigi Battistini, Giancarlo Ceccarelli, Maria Alessandroni, Gioacchino Galardo, Claudio Maria Mastroianni, Gabriella d’Ettorre
Publikováno v:
Diagnostics, Vol 11, Iss 8, p 1368 (2021)
Objectives: COVID-19 may show no peculiar signs and symptoms that may differentiate it from other infective or non-infective etiologies; thus, early recognition and prompt management are crucial to improve survival. The aim of this study was to descr
Externí odkaz:
https://doaj.org/article/7deedd0a537d4f33b6730647722cc0aa
Autor:
Francesco Cogliati Dezza, Erica Binetti, Anita Pupo, Francesca Cancelli, Gianluca Russo, Alessandra Oliva, Claudio Mastroianni
Publikováno v:
SSRN Electronic Journal.
Autor:
Gabriella d'Ettorre, Francesco Vullo, Elio Gentilini Cacciola, Alessandro Russo, M. Alessandroni, Cristian Borrazzo, Claudio Maria Mastroianni, Gioacchino Galardo, Tommaso Bucci, Valeria Filippi, Luigi Battistini, Giancarlo Ceccarelli, Luigi Celani, Erica Binetti
Publikováno v:
Diagnostics
Volume 11
Issue 8
Diagnostics, Vol 11, Iss 1368, p 1368 (2021)
Volume 11
Issue 8
Diagnostics, Vol 11, Iss 1368, p 1368 (2021)
Objectives: COVID-19 may show no peculiar signs and symptoms that may differentiate it from other infective or non-infective etiologies
thus, early recognition and prompt management are crucial to improve survival. The aim of this study was to d
thus, early recognition and prompt management are crucial to improve survival. The aim of this study was to d
Autor:
Elio Gentilini Cacciola, Luigi Battistini, Alessandro Russo, Claudio Maria Mastroianni, Erica Binetti, Gabriella d'Ettorre, Cristian Borrazzo, Giancarlo Ceccarelli
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 17
Journal of Clinical Medicine, Vol 10, Iss 3784, p 3784 (2021)
Volume 10
Issue 17
Journal of Clinical Medicine, Vol 10, Iss 3784, p 3784 (2021)
Objectives: Remdesivir is currently approved for the treatment of COVID-19. The recommendation for using remdesivir in patients with COVID-19 was based on the in vitro and in vivo activity of this drug against SARS-CoV-2. Methods: This was a prospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff4307b768e7905e5643ae5d56c95848
http://hdl.handle.net/11573/1568790
http://hdl.handle.net/11573/1568790